UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 263

Sortiert nach

An update on treatment options for pancreatic adenocarcinoma

Therapeutic Advances in Medical Oncology, 2019, Vol.11, p.1758835919875568-1758835919875568

2019

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant chemotherapy associated with isotoxic high‐dose stereotactic body radiotherapy does not increase postoperative complications after pancreaticoduodenectomy for nonmetastatic pancreatic cancer

Journal of surgical oncology, 2023-07, Vol.128 (1), p.33-40

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3687-3694

2010

Link zum Volltext

Verfügbarkeit prüfen

High‐resolution and quantitative spatial analysis reveal intra‐ductal phenotypic and functional diversification in pancreatic cancer

The Journal of pathology, 2024-01, Vol.262 (1), p.76-89

2024

Link zum Volltext

Verfügbarkeit prüfen

Dataset for the reporting of carcinoma of the exocrine pancreas: recommendations from the International Collaboration on Cancer Reporting (ICCR)

Histopathology, 2021-12, Vol.79 (6), p.902-912

2021

Link zum Volltext

Verfügbarkeit prüfen

Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resected pancreatic adenocarcinoma

European journal of cancer (1990), 2021-05, Vol.148, p.171-180

2021

Link zum Volltext

Verfügbarkeit prüfen

Vagal nerve activity predicts overall survival in metastatic pancreatic cancer, mediated by inflammation

Cancer epidemiology, 2016-02, Vol.40, p.47-51

2016

Link zum Volltext

Verfügbarkeit prüfen

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2016-05, Vol.315 (17), p.1844

2016

Link zum Volltext

Verfügbarkeit prüfen

Endoscopic ultrasound elastography for evaluation of lymph nodes and pancreatic masses: a multicenter study

World journal of gastroenterology : WJG, 2009-04, Vol.15 (13), p.1587-1593

2009

Link zum Volltext

Verfügbarkeit prüfen

Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features

Gastroenterology (New York, N.Y. 1943), 2018-12, Vol.155 (6), p.1999-2013.e3

2018

Link zum Volltext

Verfügbarkeit prüfen

Cancer patients' behaviors and attitudes toward natural health products

BMC complementary medicine and therapies, 2023-12, Vol.23 (1), p.442-442, Article 442

2023

Link zum Volltext

Verfügbarkeit prüfen

Missing metastases as a model to challenge current therapeutic algorithms in colorectal liver metastases

World journal of gastroenterology : WJG, 2016-04, Vol.22 (15), p.3937-3944

2016

Link zum Volltext

Verfügbarkeit prüfen

New challenges in perioperative management of pancreatic cancer

World journal of gastroenterology : WJG, 2015-02, Vol.21 (8), p.2281-2293

2015

Link zum Volltext

Verfügbarkeit prüfen

Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?

Therapeutic Advances in Medical Oncology, 2020, Vol.12, p.175883592093609-1758835920936093

2020

Link zum Volltext

Verfügbarkeit prüfen

Esophageal cancer: Outcome and potential benefit of esophagectomy in elderly patients

Thoracic cancer, 2022-10, Vol.13 (19), p.2699-2710

2022

Link zum Volltext

Verfügbarkeit prüfen

Isotoxic high-dose stereotactic body radiotherapy integrated in a total multimodal neoadjuvant strategy for the treatment of localized pancreatic ductal adenocarcinoma

Therapeutic advances in medical oncology, 2021, Vol.13, p.17588359211045860-17588359211045860

2021

Link zum Volltext

Verfügbarkeit prüfen

What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?

Annals of surgical oncology, 2021-10, Vol.28 (11), p.6211-6222

2021

Link zum Volltext

Verfügbarkeit prüfen

Current standards and new innovative approaches for treatment of pancreatic cancer

European journal of cancer (1990), 2016-04, Vol.57, p.10-22

2016

Link zum Volltext

Verfügbarkeit prüfen

Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer

Journal of clinical oncology, 2007-05, Vol.25 (13), p.1658-1664

2007

Link zum Volltext

Verfügbarkeit prüfen

A real-world analysis on the efficacy and tolerability of liposomal irinotecan plus 5-fluorouracil and folinic acid in metastatic pancreatic ductal adenocarcinoma in Belgium

Therapeutic advances in medical oncology, 2023-01, Vol.15, p.17588359231181500-17588359231181500

2023

Link zum Volltext

Verfügbarkeit prüfen

Addressing the challenges of pancreatic cancer: Future directions for improving outcomes

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2015-01, Vol.15 (1), p.8-18

2015

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

Oncotarget, 2017-02, Vol.8 (9), p.14408-14415

2017

Link zum Volltext

Verfügbarkeit prüfen

Massively Parallel Tumor Multigene Sequencing to Evaluate Response to Panitumumab in a Randomized Phase III Study of Metastatic Colorectal Cancer

Clinical cancer research, 2013-04, Vol.19 (7), p.1902-1912

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer

Journal of clinical oncology, 2009-05, Vol.27 (13), p.2231-2237

2009

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials

BMC cancer, 2019-02, Vol.19 (1), p.134-134, Article 134

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 263

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(253)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(147)
Life Sciences & Biomedicine
(146)
Humans
(113)
Oncology
(95)
Female
(65)
Male
(64)
Tumors
(63)
Middle Aged
(59)
Pancreatic Cancer
(58)
Aged
(54)
Adult
(44)
Biological And Medical Sciences
(44)
Medical Sciences
(44)
Chemotherapy
(40)
Prognosis
(37)
Surgery
(34)
Gastroenterology & Hepatology
(33)
Gastroenterology. Liver. Pancreas. Abdomen
(32)
Cancer
(30)
Patients
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

An update on treatment options for pancreatic adenocarcinoma

Neoadjuvant chemotherapy associated with isotoxic high‐dose stereotactic body radiotherapy does not increase postoperative complications after pancreaticoduodenectomy for nonmetastatic pancreatic cancer

Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy

High‐resolution and quantitative spatial analysis reveal intra‐ductal phenotypic and functional diversification in pancreatic cancer

Dataset for the reporting of carcinoma of the exocrine pancreas: recommendations from the International Collaboration on Cancer Reporting (ICCR)

Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resected pancreatic adenocarcinoma

Vagal nerve activity predicts overall survival in metastatic pancreatic cancer, mediated by inflammation

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial

Endoscopic ultrasound elastography for evaluation of lymph nodes and pancreatic masses: a multicenter study

Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features

Cancer patients' behaviors and attitudes toward natural health products

Missing metastases as a model to challenge current therapeutic algorithms in colorectal liver metastases

New challenges in perioperative management of pancreatic cancer

Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?

Esophageal cancer: Outcome and potential benefit of esophagectomy in elderly patients

Isotoxic high-dose stereotactic body radiotherapy integrated in a total multimodal neoadjuvant strategy for the treatment of localized pancreatic ductal adenocarcinoma

What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?

Current standards and new innovative approaches for treatment of pancreatic cancer

Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer

A real-world analysis on the efficacy and tolerability of liposomal irinotecan plus 5-fluorouracil and folinic acid in metastatic pancreatic ductal adenocarcinoma in Belgium

Addressing the challenges of pancreatic cancer: Future directions for improving outcomes

Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

Massively Parallel Tumor Multigene Sequencing to Evaluate Response to Panitumumab in a Randomized Phase III Study of Metastatic Colorectal Cancer

Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer

Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials

Suchergebnisse filtern